Elevated red cell distribution width predicts poor outcome in young patients with community acquired pneumonia

Critical Care

Zaher S Azzam²  Badira F Makhoul¹  Yoav Mazor¹  Yael Kenig³  Erel Domany¹  Eyal Braun¹ 

[1] Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Efron St. P.O.B. 9649 Bat Galim, Haifa 31096, Israel;Rappaport Family Institute for Research in the Medical Sciences, Technion, Efron St. P.O.B. 9649 Bat Galim, Haifa 31096, Israel;Department of Internal Medicine B, Rambam Health Care Campus, 1 Ha'aliya St. P.O.B. 9602 Bat Galim, Haifa 31096, Israel

关键词: Complicated Hospitalization;    Prognosis;    Mortality;    Red Blood Cell Width;    Pneumonia;   

Others  :  1094070
DOI  :  10.1186/cc10355

 received in 2011-04-03, accepted in 2011-08-11,  发布年份 2011

【 摘 要 】

Introduction

Community acquired pneumonia (CAP) is a major cause of morbidity and mortality. While there is much data about risk factors for severe outcome in the general population, there is less focus on younger group of patients. Therefore, we aimed to detect simple prognostic factors for severe morbidity and mortality in young patients with CAP.

Methods

Patients of 60 years old or younger, who were diagnosed with CAP (defined as pneumonia identified 48 hours or less from hospitalization) between March 1, 2005 and December 31, 2008 were retrospectively analyzed for risk factors for complicated hospitalization and 90-day mortality.

Results

The cohort included 637 patients. 90-day mortality rate was 6.6% and the median length of stay was 5 days. In univariate analysis, male patients and those with co-morbid conditions tended to have complicated disease. In multivariate analysis, variables associated with complicated hospitalization included post chest radiation state, prior neurologic damage, blood urea nitrogen (BUN) > 10.7 mmol/L and red cell distribution width (RDW) > 14.5%; whereas, variables associated with an increased risk of 90-day mortality included age ≥ 51 years, prior neurologic damage, immunosuppression, and the combination of abnormal white blood cells (WBC) and elevated RDW. Complicated hospitalization and mortality rate were significantly higher among patients with increased RDW regardless of the white blood cell count. Elevated RDW was associated with a significant increase in complicated hospitalization and 90-day mortality rates irrespective to hemoglobin levels.

Conclusions

In young patients with CAP, elevated RDW levels are associated with significantly higher rates of mortality and severe morbidity. RDW as a prognostic marker was unrelated with hemoglobin levels.

Trial registration

ClinicalTrials.Gov NCT00845312

【 授权许可】

   
2011 Braun et al.; licensee BioMed Central Ltd

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Pinner RW, Teutsch SM, Simonsen L, Klug LA, Graber JM, Clarke MJ, Berkelman RL: Trends in infectious diseases mortality in the United States. JAMA 1996, 275:189-193.
• [2]Fry AM, Shay DK, Holman RC, Curns AT, Anderson LJ: Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA 2005, 294:2712-2719.
• [3]Garibaldi RA: Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact. Am J Med 1985, 78:32-37.
• [4]Thomsen RW, Riis A, Norgaard M, Jacobsen J, Christensen S, McDonald CJ, Sorensen HT: Rising incidence and persistently high mortality of hospitalized pneumonia: a 10-year population-based study in Denmark. J Intern Med 2006, 259:410-417.
• [5]Renaud B, Labarere J, Coma E, Santin A, Hayon J, Gurgui M, Camus N, Roupie E, Hemery F, Herve J, Salloum M, Fine MJ, Brun-Buisson C: Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule. Critical Care (London, England) 2009, 13:R54. BioMed Central Full Text
• [6]Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN: A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250.
• [7]Ghanem-Zoubi NO, Vardi M, Laor A, Weber G, Bitterman H: Assessment of disease-severity scoring systems for patients with sepsis in general internal medicine departments. Critical Care 15:R95.
• [8]Trotter CL, Stuart JM, George R, Miller E: Increasing hospital admissions for pneumonia, England. Emerg Infect Dis 2008, 14:727-733.
• [9]Bloos F, Marshall JC, Dellinger RP, Vincent JL, Gutierrez G, Rivers E, Balk RA, Laterre PF, Angus DC, Reinhart K, Brunkhorst FM: Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study. Critical Care 15:R88.
• [10]Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB, CHARM Investigators: Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007, 50:40-47.
• [11]Oh J, Kang SM, Hong N, Choi JW, Lee SH, Park S, Shin MJ, Jang Y, Chung N: Relation between red cell distribution width with echocardiographic parameters in patients with acute heart failure. J Card Fail 2009, 15:517-522.
• [12]Hampole CV, Mehrotra AK, Thenappan T, Gomberg-Maitland M, Shah SJ: Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol 2009, 104:868-872.
• [13]Ani C, Ovbiagele B: Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci 2009, 277:103-108.
• [14]Jackson CE, Dalzell JR, Bezlyak V, Tsorlalis IK, Myles RC, Spooner R, Ford I, Petrie MC, Cobbe SM, McMurray JJ: Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure. Eur J Heart Fail 2009, 11:1152-1154.
• [15]Pascual-Figal DA, Bonaque JC, Redondo B, Caro C, Manzano-Fernandez S, Sanchez-Mas J, Garrido IP, Valdes M: Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients. Eur J Heart Fail 2009, 11:840-846.
• [16]Patel KV, Semba RD, Ferrucci L, Newman AB, Fried LP, Wallace RB, Bandinelli S, Phillips CS, Yu B, Connelly S, Shlipak MG, Chaves PH, Launer LJ, Ershler WB, Harris TB, Longo DL, Guralnik JM: Red cell distribution width and mortality in older adults: a meta-analysis. Journals of Gerontology 2010, 65:258-265.
• [17]Wang F, Pan W, Pan S, Ge J, Wang S, Chen M: Red cell distribution width as a novel predictor of mortality in ICU patients. Annals Med 2011, 43:40-46.
• [18]Fukuta H, Ohte N, Mukai S, Saeki T, Asada K, Wakami K, Kimura G: Elevated plasma levels of B-type natriuretic Peptide but not C-reactive protein are associated with higher red cell distribution width in patients with coronary artery disease. Int Heart J 2009, 50:301-312.
• [19]Pierce CN, Larson DF: Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 2005, 20:83-90.
• [20]Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC: Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 2009, 133:628-632.
• [21]Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM: Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med 2009, 169:515-523.
• [22]Perlstein TS, Weuve J, Pfeffer MA, Beckman JA: Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med 2009, 169:588-594.